Pairidex Inc. — Form D
Pairidex Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-20. The offering totals $1.1M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-02-20
- Form: D
- Accession: 0002056818-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $1.1M
- Minimum investment: $25K
- Investors: 16
- Date of first sale: 2024-05-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-538760
Issuer
- Name: Pairidex Inc.
- CIK: 0002056818
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 4340 DUNCAN AVE., ST. LOUIS, MO, 63110
- Phone: 301-580-8895
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Todd Druley | Director | ST. LOUIS, MO |
| Crystal Winkeler | Director | ST. LOUIS, MO |
| Andrew Young | Director | Daytona Beach, FL |
| Allyson Mayer | Executive Officer | ST. LOUIS, MO |
| Andrew Young | Executive Officer | Daytona Beach, FL |
More